Literature DB >> 540612

Intestinal disease and the urban environment.

H P Schedl.   

Abstract

Factors in the urban environments of highly industralized societies are important causes of disease. This review examines urban diseases of small and large intestine. The urban environment is pervaded by chemicals including drugs, food additives, pesticides, industrial products, etc., which are potential causes of disease. Examples of typical urban, as contrasted with rural, intestinal disease are considered in terms of differing etiological factors. Urban intestinal disease is examined from the following standpoints: the population at risk; the chemical agents to which the population is exposed; a model for the physiology of distribution and metabolism of chemicals in relation to the alimentary tract; the application of this model to treatment of an industrial disease; a major urban disease of the alimentary tract, carcinoma of the colon, considered in terms of this model; approaches to characterizing, identifying, and controlling urban intestinal disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 540612      PMCID: PMC1638099          DOI: 10.1289/ehp.7933115

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  44 in total

1.  Ingested mineral fibers: elimination in human urine.

Authors:  P M Cook; G F Olson
Journal:  Science       Date:  1979-04-13       Impact factor: 47.728

2.  Travelers' diarrhea and toxigenic Escherichia coli.

Authors:  S L Gorbach; B H Kean; D G Evans; D J Evans; D Bessudo
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

3.  Particle-mediated membrane uptake of chemical carcinogens studied by fluorescence spectroscopy.

Authors:  J R Lakowicz; M McNamara; L Steenson
Journal:  Science       Date:  1978-01-20       Impact factor: 47.728

4.  Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya.

Authors:  D A Sack; D C Kaminsky; R B Sack; J N Itotia; R R Arthur; A Z Kapikian; F Orskov; I Orskov
Journal:  N Engl J Med       Date:  1978-04-06       Impact factor: 91.245

5.  Digoxin bioavailability.

Authors:  D W Holt
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

6.  Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.

Authors:  M D Gold; A Blum; B N Ames
Journal:  Science       Date:  1978-05-19       Impact factor: 47.728

7.  Social inequalities undiminished.

Authors:  J N Morris
Journal:  Lancet       Date:  1979-01       Impact factor: 79.321

8.  Patterns of sexually transmitted enteric diseases in a city.

Authors:  S K Dritz; T E Ainsworth; A Back; L A Boucher; W F Garrard; R D Palmer; E River
Journal:  Lancet       Date:  1977-07-02       Impact factor: 79.321

9.  Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial.

Authors:  W J Cohn; J J Boylan; R V Blanke; M W Fariss; J R Howell; P S Guzelian
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

10.  Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning.

Authors:  J J Boylan; J L Egle; P S Guzelian
Journal:  Science       Date:  1978-02-24       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.